Suppr超能文献

链球菌纤维蛋白溶解系统(链激酶)对兔血管内血栓的溶解作用。

The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase).

作者信息

JOHNSON A J, TILLETT W S

出版信息

J Exp Med. 1952 May 1;95(5):449-64. doi: 10.1084/jem.95.5.449.

Abstract
  1. Based upon quantitative estimations of the factors that promote or retard the development and activity of the streptococcal fibrinolytic phenomenon, an active lytic system was developed within the circulating blood stream of rabbits following the intravenous infusion of streptokinase. During the infusion of adequate doses of SK, an active lytic system was observed to be present within 30 minutes following the beginning of the experiment and remained present for periods of time ranging from 1 to 20 hours depending primarily upon the concentration of SK and the duration of the infusion. Some of the biochemical changes accompanying the lytic system in vivo were: (a) a striking fall in the plasminogen; (b) a moderate fall in the serum inhibitor and the fibrinogen; and, (c) a rise in the acid-soluble nitrogen. These changes were usually self-terminating within 24 hours following the infusion of SK. In earlier studies similar trends were observed in the chest fluid of patients with hemothorax and empyema treated locally with streptokinase (22). 2. Intravascular clots, induced artificially by local applications of sodium morrhuate within the ear vein of the rabbits, were observed to liquefy and disappear in 23 of 25 rabbits during the intravenous infusion of SK into the opposite ear. The average quantity of SK necessary to effect an active lytic system was found to be about 40,000 units per kilo per hour. The clot in the ear vein was observed to be lysed completely in periods of time ranging from 3 to 7 hours after the infusion of SK was begun. Maintenance of an active lytic system for 3 to 4 additional hours was required to prevent re-formation of the clots at the original site. In 3 of 4 rabbits in which clots did reform, ACTH had been given to combat the toxic effects of the streptococcal concentrates. 3. The toxicity of the unusually large dose of the streptococcal concentrates, containing measured amounts of SK, along with other identifiable and unknown substances, was considerable, inasmuch as 8 animals eventually died. No evidence of pulmonary infarction was observed at autopsy. The administration of ACTH appeared to prevent a fatal outcome in at least 3 of the rabbits. Further studies of toxicity are in progress.
摘要
  1. 根据对促进或抑制链球菌纤溶现象发展及活性的因素进行的定量评估,在静脉输注链激酶后,兔的循环血流中形成了一个活性溶解系统。在输注足够剂量的链激酶期间,实验开始后30分钟内观察到活性溶解系统存在,并且主要取决于链激酶的浓度和输注持续时间,该系统会持续存在1至20小时不等。体内伴随溶解系统出现的一些生化变化包括:(a)纤溶酶原显著下降;(b)血清抑制剂和纤维蛋白原适度下降;以及(c)酸溶性氮增加。这些变化通常在输注链激酶后24小时内自行终止。在早期研究中,在局部用链激酶治疗的血胸和气胸患者的胸液中也观察到了类似趋势(22)。2. 在兔耳静脉局部应用鱼肝油酸钠人工诱导血管内血栓形成,在向对侧耳静脉输注链激酶期间,观察到25只兔中有23只的血栓液化并消失。发现产生活性溶解系统所需的链激酶平均量约为每千克每小时40,000单位。在开始输注链激酶后3至7小时内观察到耳静脉中的血栓完全溶解。需要再维持活性溶解系统3至4小时以防止血栓在原部位重新形成。在4只血栓确实重新形成的兔中,有3只给予了促肾上腺皮质激素以对抗链球菌浓缩物的毒性作用。3. 含有一定量链激酶以及其他可识别和未知物质的超大剂量链球菌浓缩物毒性相当大,因为最终有8只动物死亡。尸检未观察到肺梗死的证据。促肾上腺皮质激素的给药似乎至少使3只兔避免了致命结局。关于毒性的进一步研究正在进行中。

相似文献

引用本文的文献

2
Treatment of Pulmonary Embolism beyond Anticoagulation.除抗凝治疗外的肺栓塞治疗
Curr Pharm Des. 2024;30(18):1382-1385. doi: 10.2174/0113816128308493240418075258.
3
Thrombolytic Enzymes of Microbial Origin: A Review.微生物来源的溶栓酶:综述。
Int J Mol Sci. 2021 Sep 28;22(19):10468. doi: 10.3390/ijms221910468.
4
Fibrinolytic Enzymes for Thrombolytic Therapy.纤维蛋白溶解酶用于溶栓治疗。
Adv Exp Med Biol. 2019;1148:345-381. doi: 10.1007/978-981-13-7709-9_15.
5
Intravenous thrombolytics for ischemic stroke.静脉溶栓治疗缺血性脑卒中。
Neurotherapeutics. 2011 Jul;8(3):388-99. doi: 10.1007/s13311-011-0049-x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验